Combined suspension and adherent cell bioreactor system and related methods
The bioreactor system addresses the limitations of current bioreactor technologies by enabling seamless transition between suspension and adherent cell culture modes, improving productivity and product quality, and simplifying scale-up and media exchange.
Patent Information
- Application Number
- PCT/US2024/046512
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-09-29
- Filing Date
- 2024-09-13
- Publication Date
- 2025-04-03
AI Technical Summary
Current bioreactor technologies are limited to either suspension or adherent cell culture methods, lacking the capability to seamlessly transition between both modes within the same system, which hinders efficient scale-up and product quality in commercial-scale applications, particularly for AAV viral vector production.
A bioreactor system designed to operate in both suspension and adherent culture modes, featuring a media conditioning vessel and a bioreactor vessel with a perfusion flow circuit and fluid bypass, allowing for easy switching between modes to accommodate different cell culture requirements.
The system enables cost and space savings by allowing a single bioreactor to handle both suspension and adherent cultures, improving specific productivity and product quality, simplifying scale-up, and facilitating efficient media exchange, thereby addressing the limitations of current bioreactor technologies.